What is he best known for?
The fields of study he is best known for:
His scientific interests lie mostly in Biochemistry, Microbiology, Bacteria, Lipid A and Innate immune system.
His Biochemistry research incorporates elements of Pathogen, Two-dimensional nuclear magnetic resonance spectroscopy and Strain.
His Microbiology study incorporates themes from Peptidoglycan, Burkholderia cenocepacia, Gene, Virulence and Bacterial outer membrane.
Antonio Molinaro has included themes like Receptor and Glycoconjugate in his Bacteria study.
His Lipid A study is associated with Lipopolysaccharide.
His Innate immune system research incorporates themes from Gram-negative bacteria and Xanthomonas campestris.
His most cited work include:
- European consensus conference on faecal microbiota transplantation in clinical practice (413 citations)
- Multivalent glycoconjugates as anti-pathogenic agents (340 citations)
- Arabidopsis lysin-motif proteins LYM1 LYM3 CERK1 mediate bacterial peptidoglycan sensing and immunity to bacterial infection (324 citations)
What are the main themes of his work throughout his whole career to date?
Antonio Molinaro focuses on Biochemistry, Microbiology, Bacteria, Lipid A and Lipopolysaccharide.
Antonio Molinaro works mostly in the field of Biochemistry, limiting it down to concerns involving Nuclear magnetic resonance spectroscopy and, occasionally, Oligosaccharide.
The study incorporates disciplines such as Innate immune system, Cystic fibrosis and Gene, Virulence in addition to Microbiology.
He combines subjects such as Mutant, Gram-negative bacteria and Polysaccharide with his study of Bacteria.
His Lipid A research is multidisciplinary, incorporating perspectives in Glycolipid and Fatty acid.
Antonio Molinaro interconnects Burkholderia cenocepacia, Burkholderia and TLR4 in the investigation of issues within Lipopolysaccharide.
He most often published in these fields:
- Biochemistry (33.17%)
- Microbiology (30.45%)
- Bacteria (25.25%)
What were the highlights of his more recent work (between 2015-2021)?
- Biochemistry (33.17%)
- Microbiology (30.45%)
- Lipid A (20.54%)
In recent papers he was focusing on the following fields of study:
Antonio Molinaro mostly deals with Biochemistry, Microbiology, Lipid A, Bacteria and Glycan.
His studies deal with areas such as Chemical structure, Nuclear magnetic resonance spectroscopy and Bacterial cell structure as well as Biochemistry.
As a part of the same scientific family, Antonio Molinaro mostly works in the field of Microbiology, focusing on Mutant and, on occasion, Bradyrhizobium and Symbiosis.
His Lipid A research is under the purview of Lipopolysaccharide.
In his research, Biophysics is intimately related to Bacterial outer membrane, which falls under the overarching field of Lipopolysaccharide.
His Bacteria study combines topics from a wide range of disciplines, such as Oligosaccharide and Escherichia coli.
Between 2015 and 2021, his most popular works were:
- European consensus conference on faecal microbiota transplantation in clinical practice (413 citations)
- Microbiota-induced obesity requires farnesoid X receptor (193 citations)
- Microbially Produced Imidazole Propionate Impairs Insulin Signaling through mTORC1. (169 citations)
In his most recent research, the most cited papers focused on:
Antonio Molinaro spends much of his time researching Biochemistry, Microbiology, Gut flora, Bacteria and Lipid A.
His studies link Strain with Biochemistry.
His work deals with themes such as Epitope, Rhizobium and Burkholderia mallei, which intersect with Microbiology.
His Gut flora study integrates concerns from other disciplines, such as Microbiome and Endocrinology, Internal medicine, Bile acid.
His work in the fields of Bacteria, such as Rhizosphere and Bacteroides, overlaps with other areas such as Hopanoid biosynthesis and Molecular fossil.
His Lipid A study improves the overall literature in Lipopolysaccharide.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
